radiopharmaceuticals

radio volume channel
Biotech

Novartis taps Ratio for $745M radiopharmaceutical pact

Novartis has penned a deal worth $745 million in biobucks for rights to a radiopharmaceutical candidate from Ratio Therapeutics.
Gabrielle Masson Nov 18, 2024 8:00am
money dollar sign fundraise market

Radiopharma Alpha-9 raises $175M series C to fund clinical push

Oct 23, 2024 9:15am
puzzle pact

Sanofi returns to Orano with €300M for new radioligand 'pioneer'

Oct 17, 2024 5:20am
IPO initial public offering Wall Street

Pentixapharm scores $22M in IPO to advance radiopharma trials

Oct 3, 2024 10:36am
money dollar sign fundraise market

Big Pharma backers return for Aktis' $175M series B

Sep 30, 2024 8:00am
radiopharmaceutical radiotherapeutic

Sanofi pays $110M upfront for late-stage radioligand therapy

Sep 12, 2024 4:54am